Recombinant Listeria monocytogenes serovar 1/2a plcA Protein

The study of the PlcA recombinant protein is situated within the broader context of understanding pathogenic mechanisms in bacterial infections, particularly those caused by *Listeria monocytogenes*. PlcA, a phospholipase C, plays a crucial role in the virulence of this bacterium by facilitating cell-to-cell spread through the hydrolysis of phospholipids in host cell membranes. The recombinant expression of PlcA allows researchers to investigate its functional properties, structural characteristics, and interaction with host cells, contributing to a deeper understanding of the invasion strategies employed by this opportunistic pathogen. This research is particularly significant given the rising concerns regarding foodborne diseases and the impact of *Listeria* infections, especially in vulnerable populations such as pregnant women, newborns, and immunocompromised individuals. By characterizing PlcA, scientists aim to identify potential targets for therapeutic intervention and vaccine development. Moreover, this study can enhance our understanding of the molecular mechanisms underpinning bacterial pathogenicity, ultimately leading to improved public health strategies and preventive measures against *Listeria* infections. The exploration of recombinant PlcA not only sheds light on the functional dynamics of this enzyme but also holds promise for the development of novel antimicrobial therapies and better diagnostic tools.